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Abstract
Background: Shared-usage high throughput screening (HTS) facilities are becoming more common in academe as 
large-scale small molecule and genome-scale RNAi screening strategies are adopted for basic research purposes. These 
shared facilities require a unique informatics infrastructure that must not only provide access to and analysis of 
screening data, but must also manage the administrative and technical challenges associated with conducting 
numerous, interleaved screening efforts run by multiple independent research groups.
Results: We have developed Screensaver, a free, open source, web-based lab information management system (LIMS), 
to address the informatics needs of our small molecule and RNAi screening facility. Screensaver supports the storage 
and comparison of screening data sets, as well as the management of information about screens, screeners, libraries, 
and laboratory work requests. To our knowledge, Screensaver is one of the first applications to support the storage and 
analysis of data from both genome-scale RNAi screening projects and small molecule screening projects.
Conclusions: The informatics and administrative needs of an HTS facility may be best managed by a single, integrated, 
web-accessible application such as Screensaver. Screensaver has proven useful in meeting the requirements of the 
ICCB-Longwood/NSRB Screening Facility at Harvard Medical School, and has provided similar benefits to other HTS 
facilities.
Background
High throughput screening (HTS) technologies are com-
monly understood to encompass assays that generate tens
of thousands of data points, usually acquired in 96-, 384-,
or 1536-well microplate format. Use of HTS technologies
is becoming standard in academe to identify small mole-
cule research tools and to support genome-scale RNAi
screening [1-3]. High throughput screening facilities are
expensive to establish and maintain due to the cost of lab-
oratory automation, screening libraries, and personnel.
Thus, many organizations create economies of scale by
providing shared "core" HTS facilities to support multiple
screening projects run by multiple research groups. Such
facilities require an informatics infrastructure that sup-
ports access to and analysis and sharing of experimental
data.
In the case of the ICCB-Longwood/NSRB screening
facility [4] and [5] at Harvard Medical School, which was
one of the first high throughput screening facilities estab-
lished in academe, the informatics infrastructure had
developed into an ad hoc, divergent set of independent
web applications, databases, and file repositories. To
address the diverse experiment- and administrative-
based requirements of the facility, while simultaneously
addressing the need to unify its data storage and access
infrastructure, the ICCB-Longwood/NSRB facility initi-
ated development of the Screensaver web application.
Screensaver aids an HTS facility by managing the data
for its libraries and reagents, its screening experiments,
along with the screeners and daily activities associated
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Page 2 of 14with these experiments, the generated raw and annotated
data, and the follow-up requests for reagents to be cherry
picked from library stock plates. A sample screening
workflow and its interface with Screensaver is dia-
grammed in Figure 1A. Additionally, Screensaver allows
users to perform cross-screen comparisons across screen
result data and third-party annotation data, which is
available from databases such as PubChem [6], DRSC [7],
GenomeRNAi [8], ChEMBL [9], and ChemBank [10].
Figure 1 Screening Workflow and Screensaver Domain Model. A - Screening Workflow (mapped onto Screensaver Domain Model): A typical 
screening workflow is represented at the top of the figure (A). The light gray lines indicate how data generated from the workflow map onto the 
Screensaver domain model (B). The screener develops an assay protocol (1) that is entered into Screensaver by administrators and stored as a Screen 
entity. The screening facility provides the library stock plates (2) to carry out the primary screen (3). Library information, imported into Screensaver by 
administrators, is stored as Library entities. The screener and facility staff carry out data analysis, annotation, and curation (4) before the data is depos-
ited into the database by administrators. Based upon the analysis, the screener chooses library reagents for follow-up work and requests the cherry 
picks (5), which are entered into Screensaver by administrators. Administrators then use Screensaver to generate plate mapping files for cherry pick 
plate creation. The mapping files are employed by facility staff who use laboratory automation equipment to plate the cherry picks (6). Cherry pick 
plates are screened in secondary and tertiary assays by the screener (7). B - Screensaver Domain Model (primary entities): The primary entities of the 
Screensaver domain model are represented at the bottom of the figure (B) and are partitioned into color-coded groups. Two primary types of users 
are supported: Administrators and Screeners. Administrators represent the staff working at the facility. Screeners are users that conduct Screens. 
Screens, in turn, test the Reagents in one or more Libraries using protocols specified in the Screen. The Screen produces Screen Results containing a 
set of Result Values. Each Result Value is a single experimental data point for a given Library Well. A Study contains Annotation Values, which annotate 
Reagents with biologically relevant information, derived from a Screen or imported from other sources, such as journal publications or public data-
bases. A Library groups together a set of Wells and Reagents, laid out across one or more plates. A Copy represents a physical instance of a Library and 
its plates, and tracks the volumes of reagent remaining in each of its plates' wells. Activities track the events occurring in the lab as well as data updates 
made in the database (for auditing purposes), and are associated with the User that performed the activity. Cherry Pick Requests are created for a given 
Screen when cherry pick plates need to be produced for a follow-up validation assay.
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Screensaver is a database web application written in the
Java programming language. The software has been
developed using free, open source software technologies,
including the PostgreSQL relational database system [11],
Hibernate [12], Spring [13], Apache MyFaces [14], Face-
lets [15], and the Apache Tomcat servlet engine [16]. The
system's architecture thus incorporates technologies and
design techniques that are intended to facilitate rapid
modification of the software, including a clearly-defined
domain model implementation, an object-relational map-
ping framework, a component-based web user interface,
and a dependency injection framework. These architec-
tural aspects, described below in more detail, have helped
the developers update the software in response to the
quickly evolving informatics requirements of our HTS
facility. The architecture has also benefited other HTS
facilities that have already adapted Screensaver for their
own use (as detailed in "Current Usage" section).
Domain Model
Screensaver employs a domain-driven design [17] where
the conceptual domain model [18] upon which it based is
explicitly represented within the structure of the soft-
ware. The domain model layer forms the foundation of
the Screensaver application and is comprised of entity
definitions (Screen, Library, etc.) that specify the proper-
ties, relationships, constraints, and operations for each
entity type. Meta data, in the form of Java annotations,
are also specified on each entity and used by Hibernate to
map the entity properties and relationships to a physical
database schema, which can then be automatically gener-
ated. As Hibernate provides the implementation of all
persistence operations, changes made to the domain
model do not require developers to update database
access code. Most service-layer and presentation-layer
dependencies upon the domain model can be detected at
compile-time, so that the impact of domain model
changes can be reliably determined and addressed by
developers.
Since the domain model is defined as a set of Java-based
entity classes whose persistence behavior is automatically
managed, custom data import and export utilities can be
readily developed without writing database-specific code
or SQL statements. Import and export routines can be
written directly in terms of the Java entity classes that
represent the data needed. At ICCB-Longwood/NSRB,
we found this design to be a significant help during the
task of migrating data from the legacy systems that were
in use at our facility. Other facilities that need to migrate
data into or out of Screensaver should realize similar ben-
efits.
High-level, facility-specific operations that manipulate
the domain model entities are placed into separate ser-
vice, policy, and input/output layers. This design allows
the domain model layer to remain a canonical representa-
tion that can be more readily adapted for use in new
Screensaver deployments.
The primary entities of the Screensaver domain model
are highlighted in Figure 1B and are described in more
detail in the Results and Discussion section, below.
Web Application Technologies
The Screensaver web application is deployable to a Tom-
cat 5.5 servlet engine. Use of the Spring application
framework provides Screensaver with the necessary
"enterprise services," including database connectivity and
transaction management. The Spring Framework tech-
nology also provides Screensaver with a high-level, XML-
based application configuration, offering a mechanism by
which Screensaver can be customized for new deploy-
ments. For example, an alternate data access policy or
user authentication mechanism can be specified with
minimal effort. The pairing of Spring and Tomcat provide
a simple yet powerful web application environment that
avoids the use of more sophisticated, and harder to
administer, application servers.
Screensaver's user interface is based upon the JavaSer-
ver Faces and Facelets web development technologies,
allowing its web pages to be defined in terms of reusable
templates and high-level components. For users, this
results in a consistent "look and feel" across the applica-
tion. For developers, the web page definitions are concise
and easily interpreted, which facilitates modification.
Finally, as JavaServer Faces allows its user interface com-
ponents to "bind" their data contents directly to the
domain model abstraction, the user interface can be read-
ily updated in response to domain model changes.
Data Tables
Data tables are employed throughout Screensaver's user
interface. As data tables are implemented in terms of a
reusable UI component, each instance provides a consis-
tent, feature-rich user interface element for browsing, fil-
tering, and exporting data of a particular type. Data tables
provide the user with paging and sorting controls, multi-
column searching/filtering (with equality, ranking, and
similarity operators), column selection (optionally orga-
nized into hierarchical groups), and data export to appli-
cable file formats (e.g., Excel workbooks, SD files, etc.).
Internally, the data table framework allows each col-
umn to be defined in terms of the domain model entity
property (or properties) it represents. This allows devel-
opers to quickly update data table declarations to reflect
changes in the model, and also allows the framework to
automatically generate the database queries needed to
populate a table's contents. The model-based column
bindings are strongly typed, allowing the data table user
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tions for numeric, textual, and Boolean data, controlled
vocabularies, and other special-case fields, such as well
volumes and reagent concentrations. Finally, the frame-
work scales to handle large data sets by loading only
viewable data on-demand and minimizes the computa-
tional expense of filtering and sorting over large data sets
by delegating these functions to the database layer, when
necessary.
A data table can present data from multiple, related
entity types, providing the user with sophisticated, cus-
tomizable "views" into the domain model. For example,
for an RNAi library, Screensaver's "Library Contents
Browser" data table joins together entity properties from
the library's wells, the RNAi reagent in each well, the gene
targeted by each RNAi reagent, and experimental result
data from any screen that tested the well's reagent. Note
that by supporting side-by-side viewing of screen result
data from multiple screens, this data table functions as a
general mechanism for comparative analysis.
User Permissions
As Screensaver is intended to service a broad group of
users, including screeners and staff, it has been designed
to provide selective access to data and associated func-
tionality using a role-based system. User interface func-
tions are exposed or hidden, as necessary, based upon a
user's assigned data access roles. Staff members may be
granted roles that control the types of data they are
allowed to create and modify. Similarly, screeners may be
granted data access roles that control the extent of data
that they may access from others' screens.
To calculate data accessibility rights from user roles,
Screensaver provides a pluggable data access policy
mechanism where data access rights are enforced on a
per-entity instance basis. As these policies are defined via
Java code, sophisticated policies can be implemented by
developers that take into account both user roles and the
state of data. For example, the data access policy cur-
rently in use at ICCB-Longwood/NSRB supports varying
levels of mutual data sharing among screeners, such that
screens of a given data sharing level are made accessible
to users with sufficient data access roles. This creates a
tiered data access policy where screeners that are willing
to share more aspects of their own screening data (e.g.,
raw data, hit lists, or assay protocols) are allowed to
access similar levels of data from other screens.
Screeners that prefer to keep their data private are also
accommodated and, similarly, do not have access to oth-
ers' data and protocols.
Results and Discussion
Screensaver features can be partitioned into the following
categories that, by design, mirror the primary entity types
of the underlying domain model: Users, Libraries,
Screens and Studies, Cherry Pick Requests, and Activities
(Figure 1). Each of these primary entity types may be
browsed or searched via the standard data table user
interface, while the creation, viewing, and editing of
entity details is accomplished via separate "viewer" pages.
Users
Screensaver manages two categories of users, screeners
and staff. All user accounts are associated with data
access roles. Roles for screeners control the types and lev-
els of data access that are available to them. Roles for
administrators are used to selectively provide data modi-
fication permissions to specific staff members, helping to
ensure data integrity and enforce the facility's workflow
conventions. A special "Screensaver User Login" role is
used to grant or revoke login privileges to both screeners
and administrators.
For screeners (Figure 2), Screensaver maintains contact
information, relevant ID numbers, user classification
(Principal Investigator, Postdoc, Graduate Student, Tech-
nician, etc.), lab affiliation, and a list of project collabora-
tors. A system-wide configurable list of "checklist items"
is also maintained for each screener, allowing the facility
to track the status of any number of required administra-
tive tasks such as account setups, required equipment
and safety training, and inclusion on mailing lists. Finally,
Screensaver tracks the user's associated screens and the
corresponding lab activities (see below).
Libraries
A primary function of Screensaver is to manage the set of
screening libraries that are maintained at the facility (Fig-
ure 3 and 4). A "library" entity represents a set of small
molecule or RNAi reagents and their layout in 96-, 384-
or 1536-well microplates. The library entity includes the
layout of control and other special purpose wells in the
library stock plates. The reagents in a given library are
intended to form a cohesive set that is arbitrarily grouped
by supplier, target, biological function, chemical similar-
ity, date acquired, or any combination thereof. A given
reagent may exist in multiple libraries.
Screensaver provides functionality to import, query,
view, and export detailed information about each small
molecule and RNAi reagent. For both reagent types,
Screensaver maintains vendor information and plate/well
locations. For small molecule reagents, Screensaver addi-
tionally maintains common chemical names, structural
representation (in SMILES [19] and InChi [20] format)
and molecular mass. It also maintains externally-assigned
identifiers such as PubChem Compound IDs (CIDs) [6]
and ChemBank IDs [10], with appropriate links to the
respective online resources. For RNAi silencing reagents,
information about the targeted gene is stored, including
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targeted gene sequences.
From the Well Search Results page (Figure 4), a user
may locate reagents by querying on any of the reagent
entity properties. Users can also perform a batch search
for a set of wells or reagents in a single operation, by pro-
viding a set of plate/well designations or vendor reagents
identifiers, respectively. The well data can then be
exported as an Excel workbook or SD file for further anal-
ysis or communication of screen results. Details about
well contents can be viewed in the Well Viewer (Figure 4
inset), including graphical rendering of small molecule
structures.
The technical considerations of library storage and use
(e.g., minimizing freeze/thaw cycles) dictate that library
reagents be aliquoted into working copies, for use in the
screening facility. Screensaver therefore tracks the copies
that have been produced for each library. To handle con-
siderations of library reagent aging and obsolescence,
both individual library plates and individual reagent wells
can be arbitrarily retired. When library copies are used to
produce assay plates in the lab, Screensaver tracks well
reagent volume usage and reports on the remaining well
volumes on library copy plates. If necessary, individual
well volumes can be manually updated to reflect devia-
tions between expected and actual volumes (due to
pipetting imprecision, evaporation, etc.).
Library well contents are imported from Structure Data
files [23] and Microsoft Excel files for small molecule and
RNAi libraries, respectively. For small molecule libraries,
structure images can be imported for display on Screen-
saver's Well Viewer page. Screensaver provides utilities to
Figure 2 Users Browser. The Users Browser, available via the "Browse Users" and "Browse Screeners" menu options, allows facility staff to review the 
status of screeners, along with their screening projects, and their relationships to other screeners. All relevant contact information is displayed (upper 
left) and may be edited from this view after invoking the "Edit" command. The list of "Roles" provides a mechanism for controlling the data access 
permissions for the user. The "Lab Name" field, along with the "Lab Members" list, shows the members of the user's lab. The "Checklist Items" (upper 
right) allow staff to track the completion or activation status of administrative tasks. The (collapsible) "Screens" panel (bottom) shows the user's screen-
ing projects, partitioned into separate lists for Small Molecule and RNAi screens. The "Screen Associates" displays the full list of collaborators, lead 
screeners, and lab heads that are associated with the user's screening projects. A new screening project can be added from this view by invoking one 
of the "Add Screen" buttons. As for all data types in Screensaver, the navigation bar (top) and "Search" link allows staff to browse through users, within 
the context of a particular search result, ordered on a particular field. The main menu panel, shown here, is elided in subsequent figures. Note that this 
Users Browser page contains many Harvard-specific fields, including user ID numbers and checklist items. As for all fields in Screensaver, field names 
and value types can be customized by developers to the specific needs of any screening facility.
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identifiers) from online resources such as PubChem,
Entrez Gene, and ChemBank. If updated data becomes
available for a library, Screensaver allows a new version of
the library contents to be imported, while maintaining
the old versions of the data for auditing purposes. This is
particularly useful to handle the evolving nature of gene
information, but has also aided in tracking vendor-pro-
vided corrections to well and reagent information.
Screens and Studies
As its name suggests, Screensaver maintains a compre-
hensive record of the screens that are performed at an
HTS facility. A key requirement for Screensaver is that it
will store the screen information sufficient to interpret
and reproduce each screening experiment. This sort of
"minimal information" about a screening experiment is
described in detail in the work of the MIBBI (Minimum
Information for Biological and Biomedical Investigations)
Project [24,25], in particular in the MIACA (Minimal
Information About a Cellular Assay) [26] and MIARE
(Minimal Information About a RNAi Experiment) [27]
Projects. Screensaver does not currently fully match the
MIACA and MIARE recommendations, but we are work-
ing towards that goal.
In Screensaver, a "screen" entity (Figure 5, 6, 7) tracks
the progress of performing a screening assay, including a
description of its biological significance, its experimental
protocol, the raw data (from screening instrument out-
put), and the screener-curated results. An important
curated result of the screen is the set of "screening posi-
tive" reagents that have been identified as having the
desired biological activity in the screening assay. Each
screen entity also maintains considerable meta data in
order to support the administrative needs of the facility
(described in the Figure 5 legend).
Screening data are structured such that all experimen-
tal results for a given library reagent are presented in a
single table row. Stored raw screen result data are quanti-
tative. Currently, image data are not directly stored or
managed by Screensaver. For each reagent, the raw data is
associated with one or more data collection dimensions,
presented in independent columns, that include replicate
number, readout time point, and assay readout technol-
ogy (Figure 6). The raw data for each library reagent are
generally normalized and scored (currently via external
Figure 3 Library Search Results. Library Search Results, available via the "Browse Libraries" menu options, showing a summary list of the complete 
set of libraries maintained at the facility. In this example, the "Search" panel is shown expanded, allowing users to locate particular libraries based upon 
pertinent criteria. Administrator users (facility staff) will have access to additional "administrative" data columns, such as "Copies", which shows the 
names of library copies available for screening. Clicking on a library name will display more detail for the selected library.
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cations) and these intermediate analytical calculations
can be added to the screen result as additional data col-
umns. The reagents that are identified as "screening posi-
tives" are so annotated in data columns using either
Boolean (true, false), "partitioned" (strong, medium,
weak), or threshold-based numerical values.
All of the above screen result data are imported into the
system via the web application or a command-line utility,
both of which accept a Microsoft Excel file conforming to
Screensaver's screen result import file format. Once
imported, all screen result data columns are viewable in a
data table, which provides the expected sorting, filtering,
and data export features (Figure 7). Screensaver also pro-
vides a basic facility for viewing per-plate data as a heat
map (Figure 8).
In addition to screens, Screensaver provides a "study"
entity type, the purpose of which is to maintain exter-
nally-available annotations for reagents, such as data pro-
vided by journal publications or public databases. The
reagent annotations provided by a study allow biologi-
cally- or experimentally- relevant information to be uti-
lized by screeners during analysis of their own screen
result data. For example, a study might provide cell toxic-
ity or fluorescence data on small molecule reagents,
allowing a researcher to rule out reagents that might oth-
Figure 4 Well Search Results. Well Search Results, showing experimental wells for a library. The user interface for column selection is shown above, 
with the search user interface shown within the data table header. Note that in this case "MedChem Annotation" data from study 100002 has been 
appended as a data column. Similarly, by selecting available data columns under the "Data Headers (Other Screen Results)" column selection subtree, 
a user may compose a custom data table view that allows multiple screen results to be compared side-by-side. The resultant data may be filtered and 
sorted (for example, to highlight positives), and exported for external analysis. Additional description information for each well and its contents (com-
pound and silencing reagent information) may be optionally shown or hidden, including various reagent identifiers. Note the available "Deprecated" 
and "Deprecated Reason" column options, which provide a mechanism for determining whether a particular well is no longer considered appropriate 
for screening (due to library creation errors, contamination, etc.). From the Well Search Results page, a user can navigate to the Well Viewer page for 
detailed information about the library well and the reagent it contains. In this example, a well from a small molecule library is shown, which includes 
facility-assigned identifiers, a graphical rendering of the small molecule structure, SMILES and InChi structural representations, molecular mass and 
weight, and identifiers assigned by third-party databases that contain compound data (PubChem and ChemBank).
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assays, a study might provide information about known
or putative off-target effects of RNAi reagents. Study
annotation data can be imported into Screensaver using
the provided command-line utility, which accepts an
Excel file conforming to Screensaver's study import file
format.
Screensaver enables a user to make use of study data by
adding one or more study annotations into a screen result
data table as additional columns (Figure 7). By utilizing
the data table's filtering and sorting functions, the user
can assess the significance of these annotations. Similarly,
data from screens that have tested common reagents can
be merged into a single data table. This provides a basic
mechanism for performing cross-screen comparisons,
Figure 5 Screens Browser: Screen Details. The Screens Browser displays descriptive information such as screen number, screen type (RNAi or Small 
Molecule), title, summary, assay protocols, and keywords. Authorized staff may edit screen data, via the "Edit" command button. Associated users, in-
cluding the Principal Investigator (lab name), lead screener, and collaborators are maintained for each screen. The collaborators feature also provides 
a means for controlling screen result data sharing among a subset of Screensaver users. Special administrative data, viewable only by staff (red labels), 
are maintained. These include administrative comments, attached files, and funding support information. The list of attached files allows staff to as-
sociate full documents with the screen, such as screening applications and letters of support. Publications can also be attached with citation informa-
tion, which can be automatically retrieved when a PubMed ID is specified. Date-stamped screen status levels (upper right), such as "pending", 
"accepted", "ongoing", and "completed", provide a basic history of the progression of the screening effort. Lists of recent lab activities and cherry pick 
requests are shown in tables on the right, with commands for browsing and searching the full lists, and commands for adding new activities and re-
quests (available only to screen administrators). All information concerning a screen's result data can be viewed via the expandable panels at the bot-
tom of the page (see Figure 6). The screen panel, shown expanded, can be collapsed if the user wishes to view the result data only.
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by the facility. For example, this feature may be used to
compare "screening positive" reagents or reagent-specific
comments between related screens. Information derived
from this type of comparison might aid in the determina-
tion of whether different screens address functionally-
related cellular pathways.
Cherry Pick Requests
After a primary screen has been performed, screeners
will generally perform follow-up validation assays to con-
firm the biological effects of screener-selected "positive"
reagents. The reagents chosen for confirmation in the ini-
tial follow-up assay are "cherry picked" from library plates
to form a custom sub-library plated for re-screening. The
reagents chosen for this purpose constitute a "cherry pick
request" and are plated in "cherry pick plates." For a small
molecule screen, the number of compounds requested
for cherry picking is typically 0.3%-0.5% of the total num-
ber of compounds screened in the primary screen. For
genome-scale siRNA screens, cherry pick requests can
include reagents for 1%-3% of the total number of genes
screened.
Using the cherry pick request entity type (Figures 9 and
10), Screensaver manages the following workflow to for-
mat cherry pick plates for follow-up experiments:
1. The screener initiates the process by submitting his
cherry pick list as a set of library plate/well designa-
tions, which are then are entered into Screensaver as a
new cherry pick request. Screensaver reviews the set
of cherry picks and enforces policies on the cherry
pick count, uniqueness, and availability (e.g., non-
deprecated wells). For pool-based siRNAi libraries,
Screensaver automatically deconvolutes cherry picks
into constituent individual RNAi duplexes.
2. Screensaver then reserves the specified volume of
reagent from selected wells of library plates, ensuring
Figure 6 Screens Browser: Screen Result Summary. By expanding the "Screen Result Summary" and "Data Headers" sections of the Screens Brows-
er, users may view the status and description of the screen result data. Since Screensaver allows result data to be imported as it becomes available, 
Screensaver tracks when screen result data was first created, and when it was last updated. Each screen result comprises an arbitrary set of Data Head-
ers that describe the columns of "raw" and "derived" data, which are shown in the screen result data table (Figure 7). Derived data columns contain 
values calculated using values from earlier columns, and are used to record and present normalized and scored readout values, as well as the final 
determination of compounds identified as scoring positive in the screen (termed "Positives"). Positives data columns are treated specially, and may 
contain Boolean (true/false), partitioned (strong, medium, weak), or numeric values that exceed a screener-determined cutoff value. Note that for Pos-
itives data headers, users are shown the number of positives identified by the screener, both as an absolute number and as a percentage of the total 
number of experimental wells screened.
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wells. "Unfulfillable" cherry pick wells can be rolled
over into a new cherry pick request for later process-
ing.
3. A machine-readable plate mapping file is then gen-
erated to layout the reagents into the wells of one or
more cherry pick plates. This file is used by automa-
tion specialists to program the liquid handling instru-
ments to carry out the cherry picks. The plate layout
Figure 7 Screens Browser: Screen Result Data. Screens Browser, with the "Data" section expanded, showing results in a data table. Users may filter, 
sort, and export the data from this view. In this example from an RNAi screen, the table headers show that the search result has been filtered to display 
only experimental wells, with user-specified cutoff values to identify Positives scoring in both screening replicates. To gain further insights into the 
data, users may expand the "Columns" section to select data headers from other screen results and studies. In this example, three columns of anno-
tation data from study 100000 have been appended. To view a detailed description of the data in any column, the user may either hover the mouse 
pointer over the column header to view pop-up information, or may expand the "Data Headers" section to see a full description (see Figure 6).
Figure 8 Screen Viewer: Heat Map. Screen Viewer, with Heat Map section expanded. A heat map can be displayed for any plate that has been 
screened. Multiple heat maps may be displayed side-by-side in order to compare data between alternate normalization and scoring methods. Each 
well (table cell) links to the Well Viewer for detailed information on the reagent being tested.
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Page 11 of 14can be randomized, can keep arbitrary wells empty
(e.g., for controls, or to avoid edge effects, etc.), and
will order and batch together reagents by source plate
in order to work effectively with lab automation.
4. As the cherry pick plates are produced in the lab,
staff members can update Screensaver to indicate the
status of the production effort on a per-plate basis, so
as to confirm (or cancel) the reservation of reagent
volumes, or to indicate a physical plating failure,
which will repeat the reagent reservation and plate
mapping workflow for the affected plates (Figure 10).
A cherry pick request data table allows staff to effi-
ciently determine and organize pending requests and
remaining work.
Activities
Screensaver introduces a hierarchy of "activity" entity
types for tracking and auditing various events that occur
in the lab and within Screensaver itself, providing a gen-
eral mechanism for maintaining the "who", "what",
"when", and "why" for these events. Split into two major
subtypes, "lab activities" are used to represent actual
events that have been performed in the laboratory by
either screeners or staff, while "administrative activities"
represent data-related updates and decisions made by the
staff. While the hierarchy of activities is extensible, cur-
rently used types include:
Figure 9 Cherry Pick Request Viewer: Details. Administrators use the Cherry Pick Request Viewer page to manage the creation of cherry pick plates 
for validation screens. The "Details" section shows the associated screen, the screener that requested the cherry picks, the date of the request, and the 
requested volume of reagent to be transferred for each well. An approved volume is maintained, in case the requested volume cannot be provided 
by the facility. The plating options allow the screener to request a randomized layout of the reagents on the cherry pick plates, and to request an 
arbitrary set of plate wells to be left empty (for controls, or to avoid edge effects, etc.). The remaining fields (comments, cherry pick counts, and work 
status fields) allow facility staff to track the status of the plate creation effort. The "Screener Cherry Picks" section (shown collapsed) contains a table of 
all the screener-requested cherry pick wells.
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Page 12 of 14• Library Screening (lab): records the act of screening
a set of plates, which can be used to calculate library
copy usage statistics (such as freeze/thaw counts)
• Cherry Pick Liquid Transfer (lab): records the act of
creating cherry pick plates, for cherry pick request
workflow management
• Well Deprecation (administrative): records the deci-
sion to flag sets of library wells as no longer being
valid for screening
• Well Volume Correction (administrative): records
the decision to manually adjust the volumes for a set
of wells
• Checklist Item Event (administrative): records the
completion or activation/deactivation of screener-
associated "checklist items"
As each of the above activities are associated with a
specific entity type (well, user, screen, etc.), their infor-
mation appears in appropriate areas of the user interface.
However, activity data are also viewable en masse via a
data table, for general viewing and reporting purposes.
Current Usage
Screensaver has been in production use at the ICCB-
Longwood/NSRB HTS screening facility at Harvard
Medical School since June, 2007. More recently, it has
been implemented in screening facilities at the Nether-
lands Cancer Institute (NKI) [28], jointly by the A*STAR
Institute of Molecular and Cell Biology (IMCB) [29] and
Bioinformatics Institute (BII) [30], the High Throughput
Screening & Translational Research Facility (HTS-TRF)
Figure 10 Cherry Pick Request Viewer: Cherry Picks and Plates. Cherry Pick Request Viewer, showing the lower "Lab Cherry Picks" and "Cherry Pick 
Plates" sections expanded. These sections allow the facility to manage the workflow of generating the requested assay plates. "View Well Volumes" is 
used to check whether sufficient well volumes exist in any of the library copy source wells, showing a table of available well volumes for each cherry 
pick. If so, "Reserve Reagent" is used to automatically select a library copy source well for each cherry pick well, ensuring the well of the selected copy 
contains sufficient volume, and decrementing the remaining volume of that well; the "Source Copy" column displays the selected copy. "Map to 
Plates" is then used to generate the layout of the cherry picks across one or more plates, respecting the specified layout options (see Figure 9); "Cherry 
Pick Plate #" and "Destination Well" columns together show the assigned plate and well on the cherry pick plate. The set of generated plates is dis-
played in the "Cherry Pick Plates" section. Plate mapping files, which map each cherry pick from a source copy well to a cherry pick plate well, can be 
downloaded for use by the lab staff. As plates are produced in the lab, administrators can update the status of each plate to "Plated", "Failed", or "Can-
celed". Screensaver only tracks these steps, but does not enforce or otherwise check the plating outcome.
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Page 13 of 14at the Fox Chase Cancer Center [31], and the Cellular
Screening Center (CSC) at the Institute for Genomics &
Systems Biology (IGSB, University of Chicago) [32].
At ICCB-Longwood/NSRB, Screensaver is managing a
set of 400 small molecule and RNAi screens, growing at a
rate of approximately 1 to 2 new screens per week. The
database contains over 45 million "raw" data values from
screening instruments. More than 1,000 screeners are
managed by the system, most having user accounts with
login privileges. Managed libraries contain over 100,000
distinct silencing reagents (RNAi pools and duplexes are
considered distinct reagents) and more than 250,000
small molecule reagents.
Future Work
Screensaver is being actively developed and continuously
improved. Because many screeners require guidance with
data quality assessment and result analysis, Screensaver
development efforts are shifting to address these needs.
Currently, data analysis tasks are performed by external
software applications, and the resultant data are simply
imported into the system. However, integration of
Screensaver with third-party analysis tools, such as the
open source cellHTS [33] data analysis package is under-
way. For example, cellHTS integration will provide stan-
dardized mechanisms for scoring and normalizing raw
data, as well as providing quantitative and graphical qual-
ity metrics, including normalized plate intensity, heat
maps, and assay robustness metrics. Another future focus
will be improved support for cross-screen comparisons,
including per-reagent aggregate counts of "positives"
across all screens, incorporation of validation screen
results, and, potentially, dynamic incorporation of data
from public databases, such as PubChem BioAssay [34],
ChEMBL [9], and GenomeRNAi [8]. To facilitate data
sharing with the greater HTS community, we intend
Screensaver to provide functions for automating the pub-
lishing of selected data to public databases.
In response to feedback from a growing community of
open source collaborators, Screensaver may become fur-
ther modularized in design and deployment configura-
tions, and may implement additional design strategies to
minimize the effort needed to configure facility-specific
policies and extend the data model to meet facility-spe-
cific requirements. Finally, due to the maturation and
growing awareness of the MIBBI standards [24] for
experimental reporting, we intend Screensaver to provide
interoperability with the prescribed data formats. To this
end, the structure of the screening protocols, now stored
as a text (e.g., cell line, buffer recipes, transfection meth-
ods, incubation conditions, etc.), will need to be broken
out into discrete fields.
Conclusions
To support a high volume of interleaved screening proj-
ects, an HTS facility requires a sophisticated informatics
and administrative infrastructure that may be best man-
aged by a single, integrated, web-accessible application
such as Screensaver. As Screensaver has proven useful in
servicing the needs of the ICCB-Longwood/NSRB facil-
ity, it may provide similar benefits to other HTS facilities.
Screensaver was originally developed for the specific
needs of the ICCB-Longwood/NSRB facility, however,
the design of the system has already allowed other groups
with appropriately skilled informatics developers to
adopt and customize Screensaver to meet the needs of
their HTS facility. In particular, the separation of the
domain model layer from the technical infrastructure, the
use of a component-based user interface framework, and
the integration of a sophisticated data table component
combine to make the software easy to adapt and extend.
With the project team's commitment to this maintainable
and extensible design, paired with the efforts of a com-
munity of facilities providing feedback and contributions
via the open source development model, Screensaver will
continue to accommodate the growing needs of high
throughput screening facilities.
Availability and requirements
• Project name: Screensaver
• Project home page: http://sourceforge.net/projects/
screensaver/
• Operating system(s): Platform independent
• Programming language: Java
• Other requirements: Java SE 6.0, Tomcat 5.5, Postgr-
eSQL 8.3
• License: GNU GPL2
• Any restrictions to use by non-academics: none
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